Coronary Artery Disease Clinical Trials

Trials for someone you care about with coronary artery disease.

Heart & Circulation

Recruiting Drug Device Behavioral Older adults Healthy volunteers

5 trials

Comparing Prescription of Aspirin with No prescription for coronary artery disease

Explore this study →

There are 2 groups in this study. Group A receives Prescription of Aspirin. Group B receives No prescription.

One site, in Montreal

Phase 3
2 groups
One site, in Montreal
Recruiting

Official title: Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Coronary Artery Disease · Montreal Heart Institute

Testing Inclisiran against a placebo for acute coronary syndrome

Explore this study →

There are 2 groups in this study. Group A receives Inclisiran. Group B, the placebo group, receives Placebo.

Sites in Edmonton, Hamilton and 4 more cities

Phase 3
2 groups
Sites in Edmonton, Hamilton and 4 more cities
Recruiting

Official title: Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

Acute Coronary Syndrome · Novartis Pharmaceuticals

Comparing Ticagrelor with Low-dose aspirin for chronic coronary disease

Explore this study →

There are 2 groups in this study. Group A receives Ticagrelor 90 MG and Low-dose aspirin. Group B, the comparison group, receives Low-dose aspirin.

One site, in Ottawa

Phase 3
2 groups
One site, in Ottawa
Recruiting

Official title: One-Month DAPT in CABG Patients

Chronic Coronary Disease · Weill Medical College of Cornell University

Get them matched to the best-fit trials

Answer a few questions and we'll find the closest matches for coronary artery disease.

Testing Dalcetrapib against a placebo for acute coronary syndrome

Explore this study →

There are 2 groups in this study. Group A receives Dalcetrapib. Group B, the placebo group, receives Placebo.

Sites in Montreal, Toronto and 33 more cities

Phase 3
2 groups
Sites in Calgary, Edmonton and 33 more cities
Recruiting

Official title: Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome · DalCor Pharmaceuticals

Testing Dapagliflozin with CMR against a placebo for ST elevation myocardial infarction

Explore this study →

There are 2 groups in this study. Group A receives one or more of: Dapagliflozin 10mg Tab and CMR. Group B, the placebo group, receives CMR.

One site, in Ottawa

Phase 3
2 groups
One site, in Ottawa
Recruiting

Official title: Dapagliflozin in STEMI

ST Elevation Myocardial Infarction · Ottawa Heart Institute Research Corporation

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Coronary Artery Disease trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.